452 related articles for article (PubMed ID: 35897843)
21. Melatonin Effects on Non-Alcoholic Fatty Liver Disease Are Related to MicroRNA-34a-5p/Sirt1 Axis and Autophagy.
Stacchiotti A; Grossi I; García-Gómez R; Patel GA; Salvi A; Lavazza A; De Petro G; Monsalve M; Rezzani R
Cells; 2019 Sep; 8(9):. PubMed ID: 31500354
[TBL] [Abstract][Full Text] [Related]
22. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease
Li CX; Gao JG; Wan XY; Chen Y; Xu CF; Feng ZM; Zeng H; Lin YM; Ma H; Xu P; Yu CH; Li YM
World J Gastroenterol; 2019 Sep; 25(34):5120-5133. PubMed ID: 31558861
[TBL] [Abstract][Full Text] [Related]
23. Induction of autophagy via the PI3K/Akt/mTOR signaling pathway by Pueraria flavonoids improves non-alcoholic fatty liver disease in obese mice.
Sun C; Zhang J; Hou J; Hui M; Qi H; Lei T; Zhang X; Zhao L; Du H
Biomed Pharmacother; 2023 Jan; 157():114005. PubMed ID: 36384052
[TBL] [Abstract][Full Text] [Related]
24. CircLDLR acts as a sponge for miR-667-5p to regulate SIRT1 expression in non-alcoholic fatty liver disease.
Yuan X; Li Y; Wen S; Xu C; Wang C; He Y; Zhou L
Lipids Health Dis; 2022 Nov; 21(1):127. PubMed ID: 36443854
[TBL] [Abstract][Full Text] [Related]
25. Branched Chain Amino Acids Cause Liver Injury in Obese/Diabetic Mice by Promoting Adipocyte Lipolysis and Inhibiting Hepatic Autophagy.
Zhang F; Zhao S; Yan W; Xia Y; Chen X; Wang W; Zhang J; Gao C; Peng C; Yan F; Zhao H; Lian K; Lee Y; Zhang L; Lau WB; Ma X; Tao L
EBioMedicine; 2016 Nov; 13():157-167. PubMed ID: 27843095
[TBL] [Abstract][Full Text] [Related]
26. MC-LR Aggravates Liver Lipid Metabolism Disorders in Obese Mice Fed a High-Fat Diet via PI3K/AKT/mTOR/SREBP1 Signaling Pathway.
Chu H; Du C; Yang Y; Feng X; Zhu L; Chen J; Yang F
Toxins (Basel); 2022 Nov; 14(12):. PubMed ID: 36548730
[TBL] [Abstract][Full Text] [Related]
27. Hesperetin ameliorates hepatic oxidative stress and inflammation
Li J; Wang T; Liu P; Yang F; Wang X; Zheng W; Sun W
Food Funct; 2021 May; 12(9):3898-3918. PubMed ID: 33977953
[TBL] [Abstract][Full Text] [Related]
28. Activation of the SIRT1/p66shc antiapoptosis pathway via carnosic acid-induced inhibition of miR-34a protects rats against nonalcoholic fatty liver disease.
Shan W; Gao L; Zeng W; Hu Y; Wang G; Li M; Zhou J; Ma X; Tian X; Yao J
Cell Death Dis; 2015 Jul; 6(7):e1833. PubMed ID: 26203862
[TBL] [Abstract][Full Text] [Related]
29. Soluble epoxide hydrolase deficiency attenuates lipotoxic cardiomyopathy via upregulation of AMPK-mTORC mediated autophagy.
Wang L; Zhao D; Tang L; Li H; Liu Z; Gao J; Edin ML; Zhang H; Zhang K; Chen J; Zhu X; Wang D; Zeldin DC; Hammock BD; Wang J; Huang H
J Mol Cell Cardiol; 2021 May; 154():80-91. PubMed ID: 33378686
[TBL] [Abstract][Full Text] [Related]
30. A dual COX-2/sEH inhibitor improves the metabolic profile and reduces kidney injury in Zucker diabetic fatty rat.
Hye Khan MA; Hwang SH; Sharma A; Corbett JA; Hammock BD; Imig JD
Prostaglandins Other Lipid Mediat; 2016 Sep; 125():40-7. PubMed ID: 27432695
[TBL] [Abstract][Full Text] [Related]
31. Sweroside alleviates hepatic steatosis in part by activating AMPK/mTOR-mediated autophagy in mice.
Ding Y; Chen Y; Hu K; Yang Q; Li Y; Huang M
J Cell Biochem; 2023 Jul; 124(7):1012-1022. PubMed ID: 37269482
[TBL] [Abstract][Full Text] [Related]
32. Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice.
Liou CJ; Wei CH; Chen YL; Cheng CY; Wang CL; Huang WC
Cell Physiol Biochem; 2018; 49(5):1870-1884. PubMed ID: 30235452
[TBL] [Abstract][Full Text] [Related]
33. Triterpenic acids-enriched fraction from Cyclocarya paliurus attenuates insulin resistance and hepatic steatosis via PI3K/Akt/GSK3β pathway.
Zheng X; Zhao MG; Jiang CH; Sheng XP; Yang HM; Liu Y; Yao XM; Zhang J; Yin ZQ
Phytomedicine; 2020 Jan; 66():153130. PubMed ID: 31790897
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-22 alleviates alcohol-associated hepatic fibrosis, inhibits autophagy, and suppresses the PI3K/AKT/mTOR pathway in mice.
Meng YX; Zhao R; Huo LJ
Alcohol Clin Exp Res (Hoboken); 2023 Mar; 47(3):448-458. PubMed ID: 36799106
[TBL] [Abstract][Full Text] [Related]
35. COX-2/sEH Dual Inhibitor PTUPB Alleviates CCl
Zhao Z; Zhang C; Lin J; Zheng L; Li H; Qi X; Huo H; Lou X; Hammock BD; Hwang SH; Bao Y; Luo M
Front Med (Lausanne); 2021; 8():761517. PubMed ID: 35004731
[No Abstract] [Full Text] [Related]
36. Schisandrin B mitigates hepatic steatosis and promotes fatty acid oxidation by inducing autophagy through AMPK/mTOR signaling pathway.
Yan LS; Zhang SF; Luo G; Cheng BC; Zhang C; Wang YW; Qiu XY; Zhou XH; Wang QG; Song XL; Pan SY; Zhang Y
Metabolism; 2022 Jun; 131():155200. PubMed ID: 35405150
[TBL] [Abstract][Full Text] [Related]
37. Ameliorating the effect and mechanism of chitosan oligosaccharide on nonalcoholic fatty liver disease in mice.
Zhang J; Feng J; Bai Y; Che Q; Cao H; Guo J; Su Z
Food Funct; 2023 Nov; 14(23):10459-10474. PubMed ID: 37921441
[TBL] [Abstract][Full Text] [Related]
38. LB100 ameliorates nonalcoholic fatty liver disease
Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
[TBL] [Abstract][Full Text] [Related]
39. Long-chain fatty acid activates hepatocytes through CD36 mediated oxidative stress.
Liu J; Yang P; Zuo G; He S; Tan W; Zhang X; Su C; Zhao L; Wei L; Chen Y; Ruan X; Chen Y
Lipids Health Dis; 2018 Jul; 17(1):153. PubMed ID: 30016988
[TBL] [Abstract][Full Text] [Related]
40. Curcumol inhibits ferritinophagy to restrain hepatocyte senescence through YAP/NCOA4 in non-alcoholic fatty liver disease.
Qi X; Song A; Ma M; Wang P; Zhang X; Lu C; Zhang J; Zheng S; Jin H
Cell Prolif; 2021 Sep; 54(9):e13107. PubMed ID: 34346124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
